Altimmune Inc. said it was no longer compliant with Nasdaq's $1 minimum bid price listing requirement.
The Gaithersburg, Md.-based biotechnology company has until Nov. 13 to regain compliance for which its stock price must close at $1 per share for 10 consecutive business days.
